Pure GLP-1 agonists vs dual agonists: why the distinction matters The receptor target determines the side effect profile, efficacy ceiling, and patient selection criteria
The commentary concluded that, based on current knowledge, patients should not stop taking semaglutide on this account alone, especially given potential increases in morbidity from conditions that are well controlled by semaglutide, potential adverse effects of hyperglycemia caused by abrupt cessation of treatment, and the seemingly low absolute risk of NAION
This may be inconvenient for some patients
The use of agents increasing GLP-1 receptor signaling may be associated with a neuroprotective effect in Alzheimers disease (AD) by preventing declines in cortical activity, decreasing A-levels and improving cognitive function as well as the volume of gray matter of patients
2 Faculty of Medicine, Yarsi University, Jakarta, Indonesia
Is CJC-1295 an anabolic steroid